FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2065222316> ?p ?o ?g. }

• W2065222316 endingPage "520" @default.
• W2065222316 startingPage "513" @default.
• W2065222316 abstract "In vitro activity of doripenem and comparator antimicrobial agents was evaluated against Gram-negative bacilli recently isolated from Brazilian private hospitals that were enrolled in the INVITA-A-DORI Brazilian Study. A total of 805 unique Gram-negative bacilli were collected from patients hospitalized at 18 medical centers between May/08 and March/09. Each hospital was asked to submit 50 single Gram-negative bacilli isolated from blood, lower respiratory tract or intraabdominal secretions. Bacterial identification was confirmed and antimicrobial susceptibility testing was performed using Clinical Laboratory Standards Institute (CLSI) microdilution method at a central laboratory. CLSI M100-S21 (2011) or US-FDA package insert criteria (tigecycline) was used for interpretation of the antimicrobial susceptibility results. Doripenem was as active as meropenem and more active than imipenem against E. coli and K. pneumoniae isolates. A total of 50.0% of Enterobacter spp. isolates were resistant to ceftazidime but 85.7% of them were inhibited at doripenem MICs ≤ 1 μg/mL. Polymyxin B was the only agent to show potent activity against Acinetobacter spp. (MIC 50/90 , ≤ 0.5/1 μg/mL) and P. aeruginosa (MIC 50/90 , 1/2 μg/mL). Although high rates of imipenem (53.1%) and meropenem (44.5%) resistance were detected among P. aeruginosa , doripenem showed MIC 50 of 16 μg/mL against imipenem-resistant P. aeruginosa and inhibited a greater number of imipenem-resistant P. aeruginosa (10.5%) at MIC values of ≤ 4 μg/mL than did meropenem (0.0%). In this study, doripenem showed similar in vitro activity to that of meropenem and retained some activity against imipenem-resistant P. aeruginosa isolated from Brazilian medical centers." @default.
• W2065222316 created "2016-06-24" @default.
• W2065222316 creator A5002109133 @default.
• W2065222316 creator A5013666431 @default.
• W2065222316 creator A5058481875 @default.
• W2065222316 creator A5059914416 @default.
• W2065222316 creator A5070169486 @default.
• W2065222316 date "2011-11-01" @default.
• W2065222316 modified "2023-10-18" @default.
• W2065222316 title "Antimicrobial activity of doripenem against Gram-negative pathogens: results from INVITA-A-DORI Brazilian Study" @default.
• W2065222316 cites W1867523216 @default.
• W2065222316 cites W1972079818 @default.
• W2065222316 cites W1972497850 @default.
• W2065222316 cites W1978169227 @default.
• W2065222316 cites W1989122238 @default.
• W2065222316 cites W2001280008 @default.
• W2065222316 cites W2005657074 @default.
• W2065222316 cites W2032768856 @default.
• W2065222316 cites W2048018784 @default.
• W2065222316 cites W2051090352 @default.
• W2065222316 cites W2056751868 @default.
• W2065222316 cites W2074575515 @default.
• W2065222316 cites W2091846368 @default.
• W2065222316 cites W2101404584 @default.
• W2065222316 cites W2109284475 @default.
• W2065222316 cites W2110515697 @default.
• W2065222316 cites W2110556487 @default.
• W2065222316 cites W2114021988 @default.
• W2065222316 cites W2120865397 @default.
• W2065222316 cites W2130126087 @default.
• W2065222316 cites W2138246800 @default.
• W2065222316 cites W2140469508 @default.
• W2065222316 cites W2142362776 @default.
• W2065222316 cites W2145593972 @default.
• W2065222316 cites W2156208059 @default.
• W2065222316 cites W2157687806 @default.
• W2065222316 cites W2161703824 @default.
• W2065222316 cites W2162067003 @default.
• W2065222316 cites W2169499475 @default.
• W2065222316 doi "https://doi.org/10.1016/s1413-8670(11)70244-6" @default.
• W2065222316 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/22218508" @default.
• W2065222316 hasPublicationYear "2011" @default.
• W2065222316 type Work @default.
• W2065222316 sameAs 2065222316 @default.
• W2065222316 citedByCount "5" @default.
• W2065222316 countsByYear W20652223162012 @default.
• W2065222316 countsByYear W20652223162014 @default.
• W2065222316 countsByYear W20652223162015 @default.
• W2065222316 countsByYear W20652223162016 @default.
• W2065222316 crossrefType "journal-article" @default.
• W2065222316 hasAuthorship W2065222316A5002109133 @default.
• W2065222316 hasAuthorship W2065222316A5013666431 @default.
• W2065222316 hasAuthorship W2065222316A5058481875 @default.
• W2065222316 hasAuthorship W2065222316A5059914416 @default.
• W2065222316 hasAuthorship W2065222316A5070169486 @default.
• W2065222316 hasBestOaLocation W20652223161 @default.
• W2065222316 hasConcept C176947019 @default.
• W2065222316 hasConcept C2776315533 @default.
• W2065222316 hasConcept C2776685102 @default.
• W2065222316 hasConcept C2776968632 @default.
• W2065222316 hasConcept C2777027569 @default.
• W2065222316 hasConcept C2777637488 @default.
• W2065222316 hasConcept C2777821550 @default.
• W2065222316 hasConcept C2778368673 @default.
• W2065222316 hasConcept C2778523567 @default.
• W2065222316 hasConcept C2779375183 @default.
• W2065222316 hasConcept C2779631663 @default.
• W2065222316 hasConcept C2780950330 @default.
• W2065222316 hasConcept C4937899 @default.
• W2065222316 hasConcept C501593827 @default.
• W2065222316 hasConcept C523546767 @default.
• W2065222316 hasConcept C54355233 @default.
• W2065222316 hasConcept C71924100 @default.
• W2065222316 hasConcept C86803240 @default.
• W2065222316 hasConcept C89423630 @default.
• W2065222316 hasConcept C94665300 @default.
• W2065222316 hasConceptScore W2065222316C176947019 @default.
• W2065222316 hasConceptScore W2065222316C2776315533 @default.
• W2065222316 hasConceptScore W2065222316C2776685102 @default.
• W2065222316 hasConceptScore W2065222316C2776968632 @default.
• W2065222316 hasConceptScore W2065222316C2777027569 @default.
• W2065222316 hasConceptScore W2065222316C2777637488 @default.
• W2065222316 hasConceptScore W2065222316C2777821550 @default.
• W2065222316 hasConceptScore W2065222316C2778368673 @default.
• W2065222316 hasConceptScore W2065222316C2778523567 @default.
• W2065222316 hasConceptScore W2065222316C2779375183 @default.
• W2065222316 hasConceptScore W2065222316C2779631663 @default.
• W2065222316 hasConceptScore W2065222316C2780950330 @default.
• W2065222316 hasConceptScore W2065222316C4937899 @default.
• W2065222316 hasConceptScore W2065222316C501593827 @default.
• W2065222316 hasConceptScore W2065222316C523546767 @default.
• W2065222316 hasConceptScore W2065222316C54355233 @default.
• W2065222316 hasConceptScore W2065222316C71924100 @default.
• W2065222316 hasConceptScore W2065222316C86803240 @default.
• W2065222316 hasConceptScore W2065222316C89423630 @default.
• W2065222316 hasConceptScore W2065222316C94665300 @default.
• W2065222316 hasIssue "6" @default.
• W2065222316 hasLocation W20652223161 @default.

• next